Fool.com
The World's Greatest Investing Community
Results 21 - 30 of 9560 : Previous 1 2 3 4 5 6 7 8 9 Next
It still has a big bet ahead of it, though.
Two formerly friendly companies begin a feud.
This Just In: Upgrades and Downgrades
Needham suspends clinical trial of buying Geron.
Tried-and-true tips for finding hugely profitable stocks.
Finally Convinced? Benlysta Works!
Human Genome Sciences succeeds where others have failed.
Still the Best Company I've Ever Seen
In-N-Out Burger just keeps getting better.
3 Stocks That Blew the Market Away
Beat the market and the world will beat a path to your door.
Earnings? Yawn. Trial Data? Moving!
For Human Genome Sciences investors, the anticipation is frightening.
The solar sultan whiffs on revenue and gets slammed.
New Android smartphones are poised to challenge the iPhone.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK